Long term safety and efficacy of open-label infliximab for SLE

被引：0
|
作者：
Aringer, M. [1 ]
Houssiau, F. [2 ,3 ]
Graninger, W. B. [4 ]
Feier, E. [5 ]
Steiner, G. [5 ]
Smolen, J. S. [5 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Tech Univ Dresden, Univ Clin Ctr Carl Gustav Carus, Dresden, Germany
[3] Univ Catholique Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium
[4] Med Univ Graz, Graz, Austria
[5] Med Univ Vienna, Vienna, Austria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：455 / 455
页数：1
相关论文
共 50 条
  • [21] Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine
    Sakai, Fumihiko
    Takeshima, Takao
    Tatsuoka, Yoshihisa
    Hirata, Koichi
    Cheng, Sunfa
    Numachi, Yotaro
    Peng, Cheng
    Xue, Fei
    Mikol, Daniel D.
    HEADACHE, 2021, 61 (04): : 653 - 661
  • [22] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [23] Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal
    Lemoine, Patrick
    Garfinkel, Doron
    Laudon, Moshe
    Nir, Tali
    Zisapel, Nava
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2011, 7 : 301 - 311
  • [24] Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan
    Inoue, Yushi
    Ohtsuka, Yoko
    EPILEPSY RESEARCH, 2015, 113 : 90 - 97
  • [25] Safety of long-term use of linezolid: results of an open-label study
    Vazquez, Jose A.
    Arnold, Anthony C.
    Swanson, Robert N.
    Biswas, Pinaki
    Bassetti, Matteo
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1347 - 1354
  • [26] Assessment of the Long-term Safety and Efficacy of Erenumab During Open-label Treatment of Subjects with Chronic Migraine
    Tepper, S. J.
    Ashina, M.
    Brandes, J.
    Dolezil, D.
    Silberstein, S. D.
    Winner, P. K.
    Zhang, F.
    Cheng, S.
    Mikol, D. D.
    HEADACHE, 2018, 58 (08): : 1302 - 1303
  • [27] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY
    Banerji, A.
    Hao, J.
    Yu, M.
    Bernstein, J.
    Johnston, D.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S21 - S21
  • [28] Long-term safety and efficacy of open-label dupilumab in patients with moderate-to-severe atopic dermatitis
    Deleuran, M.
    Thaci, D.
    Beck, L.
    Forman, S.
    Soong, W.
    Hussain, I.
    Bissonnette, R.
    Bouaziz, J.
    Gelfand, J.
    Lawrence, S.
    Chen, Z.
    Akinlade, B.
    Gadkari, A.
    Eckert, L.
    Graham, N.
    Ardeleanu, M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 34 - 34
  • [29] Assessment of the long-term safety and efficacy of erenumab during open-label treatment of subjects with chronic migraine
    Tepper, Stewart
    Ashina, Messoud
    Reuter, Uwe
    Brandes, Jan L.
    Dolezil, David
    Silberstein, Stephen
    Winner, Paul
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [30] Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
    Ruperto, Nicolino
    Lovell, Daniel J.
    Cuttica, Ruben
    Woo, Patricia
    Meiorin, Silvia
    Wouters, Carine
    Silverman, Earl D.
    Balogh, Zsolt
    Henrickson, Michael
    Davidson, Joyce
    Foeldvari, Ivan
    Imundo, Lisa
    Simonini, Gabriele
    Oppermann, Joachim
    Xu, Stephen
    Shen, Yaung-Kaung
    Visvanathan, Sudha
    Fasanmade, Adedigbo
    Mendelsohn, Alan
    Martini, Alberto
    Giannini, Edward H.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 718 - 722
12345